Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
22,766,960
-
Total 13F shares
-
9,458,074
-
Share change
-
+474,964
-
Total reported value
-
$1,184,436,498
-
Put/Call ratio
-
48%
-
Price per share
-
$125.26
-
Number of holders
-
133
-
Value change
-
+$61,292,852
-
Number of buys
-
69
-
Number of sells
-
52
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) as of Q1 2019
As of 31 Mar 2019,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock, $0.0001 par value per share (MDGL) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,458,074 shares.
The largest 10 holders included
Capital Research Global Investors, BAKER BROS. ADVISORS LP, HealthCor Management, L.P., VANGUARD GROUP INC, STATE STREET CORP, BlackRock Inc., ARMISTICE CAPITAL, LLC, JENNISON ASSOCIATES LLC, Avoro Capital Advisors LLC, and ALLIANCEBERNSTEIN L.P..
This page lists
133
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.